

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 9.30055742 |
| 2 | * regulation of sequestering of triglyceride (GO:0010889) | 9.08801364 |
| 3 | tricarboxylic acid cycle (GO:0006099) | 8.80076300 |
| 4 | carnitine shuttle (GO:0006853) | 8.74260423 |
| 5 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 8.57825217 |
| 6 | fatty acid transmembrane transport (GO:1902001) | 8.22079390 |
| 7 | regulation of coenzyme metabolic process (GO:0051196) | 8.15578699 |
| 8 | regulation of cofactor metabolic process (GO:0051193) | 8.15578699 |
| 9 | regulation of fatty acid oxidation (GO:0046320) | 7.62844244 |
| 10 | NADH metabolic process (GO:0006734) | 7.23307635 |
| 11 | biotin metabolic process (GO:0006768) | 7.20319519 |
| 12 | fatty acid beta-oxidation (GO:0006635) | 6.70068411 |
| 13 | carnitine transmembrane transport (GO:1902603) | 6.63535783 |
| 14 | positive regulation of fatty acid oxidation (GO:0046321) | 6.49668812 |
| 15 | regulation of sulfur metabolic process (GO:0042762) | 6.45099075 |
| 16 | acyl-CoA biosynthetic process (GO:0071616) | 6.35729816 |
| 17 | thioester biosynthetic process (GO:0035384) | 6.35729816 |
| 18 | brown fat cell differentiation (GO:0050873) | 6.29835514 |
| 19 | amino-acid betaine transport (GO:0015838) | 6.08203945 |
| 20 | carnitine transport (GO:0015879) | 6.08203945 |
| 21 | fatty acid homeostasis (GO:0055089) | 6.05974659 |
| 22 | white fat cell differentiation (GO:0050872) | 5.98736385 |
| 23 | respiratory electron transport chain (GO:0022904) | 5.98679397 |
| 24 | diacylglycerol metabolic process (GO:0046339) | 5.96166009 |
| 25 | triglyceride catabolic process (GO:0019433) | 5.96009391 |
| 26 | electron transport chain (GO:0022900) | 5.85398478 |
| 27 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 5.85044990 |
| 28 | succinate metabolic process (GO:0006105) | 5.79841927 |
| 29 | fatty acid oxidation (GO:0019395) | 5.75075469 |
| 30 | fatty acid catabolic process (GO:0009062) | 5.73107155 |
| 31 | acetyl-CoA metabolic process (GO:0006084) | 5.72870281 |
| 32 | branched-chain amino acid catabolic process (GO:0009083) | 5.68468028 |
| 33 | lipid oxidation (GO:0034440) | 5.65017237 |
| 34 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.48467971 |
| 35 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 5.45780941 |
| 36 | neutral lipid catabolic process (GO:0046461) | 5.39240126 |
| 37 | acylglycerol catabolic process (GO:0046464) | 5.39240126 |
| 38 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.33669317 |
| 39 | oxidative phosphorylation (GO:0006119) | 5.28829707 |
| 40 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 5.27741978 |
| 41 | coenzyme A biosynthetic process (GO:0015937) | 5.20712756 |
| 42 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 5.10341056 |
| 43 | branched-chain amino acid metabolic process (GO:0009081) | 5.08547298 |
| 44 | transcytosis (GO:0045056) | 5.00077571 |
| 45 | triglyceride biosynthetic process (GO:0019432) | 4.93634224 |
| 46 | valine metabolic process (GO:0006573) | 4.93354016 |
| 47 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.86507480 |
| 48 | intracellular lipid transport (GO:0032365) | 4.86291039 |
| 49 | CDP-diacylglycerol metabolic process (GO:0046341) | 4.85887430 |
| 50 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.79745899 |
| 51 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.79344228 |
| 52 | plasma lipoprotein particle clearance (GO:0034381) | 4.74701809 |
| 53 | neutral lipid biosynthetic process (GO:0046460) | 4.72242726 |
| 54 | acylglycerol biosynthetic process (GO:0046463) | 4.72242726 |
| 55 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.66593129 |
| 56 | regulation of glycogen (starch) synthase activity (GO:2000465) | 4.62588678 |
| 57 | short-chain fatty acid metabolic process (GO:0046459) | 4.61762788 |
| 58 | ethanol oxidation (GO:0006069) | 4.60678437 |
| 59 | lipid particle organization (GO:0034389) | 4.59707473 |
| 60 | tricarboxylic acid metabolic process (GO:0072350) | 4.55792921 |
| 61 | positive regulation of glomerulus development (GO:0090193) | 4.50297769 |
| 62 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.44099234 |
| 63 | regulation of triglyceride catabolic process (GO:0010896) | 4.43785200 |
| 64 | regulation of cholesterol storage (GO:0010885) | 4.41503509 |
| 65 | quaternary ammonium group transport (GO:0015697) | 4.40194975 |
| 66 | cardiolipin metabolic process (GO:0032048) | 4.39261530 |
| 67 | monocarboxylic acid catabolic process (GO:0072329) | 4.38945658 |
| 68 | protein heterotrimerization (GO:0070208) | 4.38460206 |
| 69 | thioester metabolic process (GO:0035383) | 4.37275029 |
| 70 | acyl-CoA metabolic process (GO:0006637) | 4.37275029 |
| 71 | coenzyme A metabolic process (GO:0015936) | 4.30582773 |
| 72 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 4.30444352 |
| 73 | cellular response to epinephrine stimulus (GO:0071872) | 4.27807365 |
| 74 | low-density lipoprotein particle clearance (GO:0034383) | 4.25650119 |
| 75 | polyol transport (GO:0015791) | 4.25370895 |
| 76 | negative regulation of fatty acid metabolic process (GO:0045922) | 4.23499701 |
| 77 | regulation of fatty acid metabolic process (GO:0019217) | 4.19341785 |
| 78 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 4.19286853 |
| 79 | long-chain fatty acid transport (GO:0015909) | 4.17535095 |
| 80 | lysine catabolic process (GO:0006554) | 4.17138009 |
| 81 | lysine metabolic process (GO:0006553) | 4.17138009 |
| 82 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.14526587 |
| 83 | positive regulation of cholesterol efflux (GO:0010875) | 4.12872643 |
| 84 | response to dietary excess (GO:0002021) | 4.12371990 |
| 85 | negative regulation of granulocyte differentiation (GO:0030853) | 4.10798062 |
| 86 | glycerolipid catabolic process (GO:0046503) | 4.09232720 |
| 87 | alpha-linolenic acid metabolic process (GO:0036109) | 4.09068996 |
| 88 | retinol metabolic process (GO:0042572) | 4.06547764 |
| 89 | primary alcohol metabolic process (GO:0034308) | 4.02915842 |
| 90 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.01529493 |
| 91 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 4.01488057 |
| 92 | phospholipid homeostasis (GO:0055091) | 3.99268602 |
| 93 | phosphatidic acid metabolic process (GO:0046473) | 3.97799780 |
| 94 | phosphatidic acid biosynthetic process (GO:0006654) | 3.97799780 |
| 95 | pantothenate metabolic process (GO:0015939) | 3.91475832 |
| 96 | positive regulation of p38MAPK cascade (GO:1900745) | 3.83888757 |
| 97 | * lipid storage (GO:0019915) | 3.83249287 |
| 98 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.76087204 |
| 99 | negative regulation of macrophage differentiation (GO:0045650) | 3.73201774 |
| 100 | ethanol metabolic process (GO:0006067) | 3.71981363 |
| 101 | proline transport (GO:0015824) | 3.70462838 |
| 102 | positive regulation of sterol transport (GO:0032373) | 3.68878765 |
| 103 | positive regulation of cholesterol transport (GO:0032376) | 3.68878765 |
| 104 | L-serine transport (GO:0015825) | 3.65708523 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.64870563 |
| 106 | fatty acid transport (GO:0015908) | 3.62024103 |
| 107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.61089151 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.61089151 |
| 109 | glycine transport (GO:0015816) | 3.59581146 |
| 110 | triglyceride metabolic process (GO:0006641) | 3.59087912 |
| 111 | carnitine metabolic process (GO:0009437) | 3.58774973 |
| 112 | response to epinephrine (GO:0071871) | 3.55525987 |
| 113 | negative regulation of protein autophosphorylation (GO:0031953) | 3.53053358 |
| 114 | cellular response to lithium ion (GO:0071285) | 3.52447944 |
| 115 | cellular lipid catabolic process (GO:0044242) | 3.51714964 |
| 116 | inner mitochondrial membrane organization (GO:0007007) | 3.50661879 |
| 117 | oligosaccharide biosynthetic process (GO:0009312) | 3.50408333 |
| 118 | glycerol metabolic process (GO:0006071) | 3.50105012 |
| 119 | ATP synthesis coupled proton transport (GO:0015986) | 3.47397655 |
| 120 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.47397655 |
| 121 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.44114446 |
| 122 | alanine transport (GO:0032328) | 3.39758961 |
| 123 | negative regulation of metanephros development (GO:0072217) | 3.39497283 |
| 124 | quinone biosynthetic process (GO:1901663) | 3.39272636 |
| 125 | ubiquinone biosynthetic process (GO:0006744) | 3.39272636 |
| 126 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.38111723 |
| 127 | acylglycerol metabolic process (GO:0006639) | 3.37409532 |
| 128 | linoleic acid metabolic process (GO:0043651) | 3.35232447 |
| 129 | neutral lipid metabolic process (GO:0006638) | 3.33561192 |
| 130 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.33553426 |
| 131 | fatty acid elongation (GO:0030497) | 3.32796625 |
| 132 | aerobic respiration (GO:0009060) | 3.31876575 |
| 133 | * positive regulation of lipid storage (GO:0010884) | 3.31553092 |
| 134 | negative regulation of lipid storage (GO:0010888) | 3.31390692 |
| 135 | oxaloacetate metabolic process (GO:0006107) | 3.30117479 |
| 136 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.29966688 |
| 137 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.29620724 |
| 138 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.28838834 |
| 139 | pentose-phosphate shunt (GO:0006098) | 3.28262235 |
| 140 | negative regulation of phagocytosis (GO:0050765) | 3.26430066 |
| 141 | ovulation from ovarian follicle (GO:0001542) | 3.26257801 |
| 142 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.25864884 |
| 143 | acylglycerol homeostasis (GO:0055090) | 3.25397452 |
| 144 | triglyceride homeostasis (GO:0070328) | 3.25397452 |
| 145 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.24390427 |
| 146 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.24390427 |
| 147 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.24390427 |
| 148 | negative regulation of gluconeogenesis (GO:0045721) | 3.21200579 |
| 149 | cGMP-mediated signaling (GO:0019934) | 3.20515461 |
| 150 | regulation of receptor binding (GO:1900120) | 3.12439016 |
| 151 | protein localization to cell surface (GO:0034394) | 3.12410026 |
| 152 | hair cycle (GO:0042633) | 3.11850554 |
| 153 | molting cycle (GO:0042303) | 3.11850554 |
| 154 | positive regulation of glucose import (GO:0046326) | 3.11026451 |
| 155 | serine transport (GO:0032329) | 3.09977854 |
| 156 | regulation of vasculogenesis (GO:2001212) | 3.09705827 |
| 157 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.08685634 |
| 158 | alditol metabolic process (GO:0019400) | 3.07194340 |
| 159 | positive regulation of glycolytic process (GO:0045821) | 3.05419562 |
| 160 | barbed-end actin filament capping (GO:0051016) | 3.04580514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 7.93463586 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.51864603 |
| 3 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.80361941 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.56232447 |
| 5 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 3.42022812 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.23050305 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.95110931 |
| 8 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.83537758 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.57437315 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.37147377 |
| 11 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.34151473 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.30119540 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.18378504 |
| 14 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.18251886 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.09055097 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 15.0861033 |
| 17 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.98303223 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.84344448 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.73904921 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.68106855 |
| 21 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.66967566 |
| 22 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.56928426 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.53009766 |
| 24 | RXR_22108803_ChIP-Seq_LS180_Human | 1.52825812 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49050707 |
| 26 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.41761045 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.33736412 |
| 28 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.33454113 |
| 29 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.31735968 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28370025 |
| 31 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.27031276 |
| 32 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.26981319 |
| 33 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.26086149 |
| 34 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25680684 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25334335 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25044687 |
| 37 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.23183197 |
| 38 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.23183197 |
| 39 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.15771454 |
| 40 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.15575032 |
| 41 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.15575032 |
| 42 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.15506445 |
| 43 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.14934423 |
| 44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11709295 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10769535 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08868328 |
| 47 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.08266079 |
| 48 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06705783 |
| 49 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.05087780 |
| 50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03383663 |
| 51 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.02268173 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02150217 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01595752 |
| 54 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.01161787 |
| 55 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.99958838 |
| 56 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.99786819 |
| 57 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.99238202 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 0.98622430 |
| 59 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.98199611 |
| 60 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98028871 |
| 61 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.97572411 |
| 62 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.94730902 |
| 63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93735613 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93287409 |
| 65 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.93100749 |
| 66 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.92546474 |
| 67 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92112799 |
| 68 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91656545 |
| 69 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90695775 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.90171415 |
| 71 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.89396988 |
| 72 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88781203 |
| 73 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.88710239 |
| 74 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.86685962 |
| 75 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.86423408 |
| 76 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85662444 |
| 77 | CBP_21632823_ChIP-Seq_H3396_Human | 0.85615466 |
| 78 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85064813 |
| 79 | ATF3_27146783_Chip-Seq_COLON_Human | 0.85060732 |
| 80 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.84703271 |
| 81 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.83310708 |
| 82 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.83263535 |
| 83 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83187328 |
| 84 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.81244485 |
| 85 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.80566547 |
| 86 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.79785179 |
| 87 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.79785179 |
| 88 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.78648907 |
| 89 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.78081906 |
| 90 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.77280116 |
| 91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77272175 |
| 92 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.76713281 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76565004 |
| 94 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.76534426 |
| 95 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.75521925 |
| 96 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.74391869 |
| 97 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.73362926 |
| 98 | P68_20966046_ChIP-Seq_HELA_Human | 0.73281022 |
| 99 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72973242 |
| 100 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.72581615 |
| 101 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.72566651 |
| 102 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72106188 |
| 103 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.70785786 |
| 104 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.70059309 |
| 105 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.70010050 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.68371990 |
| 107 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.68075763 |
| 108 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.67660134 |
| 109 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66979541 |
| 110 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.65495500 |
| 111 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65473511 |
| 112 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64965803 |
| 113 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.64686854 |
| 114 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.64653700 |
| 115 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.63813234 |
| 116 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.63473733 |
| 117 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.63341498 |
| 118 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.61704758 |
| 119 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.61573502 |
| 120 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.61279270 |
| 121 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.59858524 |
| 122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.58993140 |
| 123 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.58651918 |
| 124 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.57279640 |
| 125 | GATA1_22025678_ChIP-Seq_K562_Human | 0.56821936 |
| 126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.56709808 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.56709808 |
| 128 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.56134672 |
| 129 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.55661648 |
| 130 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.55165039 |
| 131 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.54408203 |
| 132 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.53317580 |
| 133 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.52745350 |
| 134 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.52193836 |
| 135 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.51217446 |
| 136 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.50811198 |
| 137 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.50405507 |
| 138 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.50191185 |
| 139 | AR_25329375_ChIP-Seq_VCAP_Human | 0.49379733 |
| 140 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.49195338 |
| 141 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.49092509 |
| 142 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.49025468 |
| 143 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.48536780 |
| 144 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.48333798 |
| 145 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.48076048 |
| 146 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.47848467 |
| 147 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.46656359 |
| 148 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.45619595 |
| 149 | GATA2_19941826_ChIP-Seq_K562_Human | 0.44827269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 6.91789970 |
| 2 | MP0004130_abnormal_muscle_cell | 5.86268040 |
| 3 | MP0005666_abnormal_adipose_tissue | 5.45041453 |
| 4 | MP0003646_muscle_fatigue | 5.36618223 |
| 5 | MP0004185_abnormal_adipocyte_glucose | 5.20921104 |
| 6 | MP0001881_abnormal_mammary_gland | 4.20261864 |
| 7 | * MP0002971_abnormal_brown_adipose | 3.76721229 |
| 8 | MP0005375_adipose_tissue_phenotype | 3.57005030 |
| 9 | MP0006036_abnormal_mitochondrial_physio | 3.48141149 |
| 10 | MP0000013_abnormal_adipose_tissue | 2.68249244 |
| 11 | * MP0005535_abnormal_body_temperature | 2.56416318 |
| 12 | MP0000003_abnormal_adipose_tissue | 2.30966604 |
| 13 | * MP0002118_abnormal_lipid_homeostasis | 2.11720765 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.11089184 |
| 15 | MP0002332_abnormal_exercise_endurance | 2.10604684 |
| 16 | MP0005330_cardiomyopathy | 2.08707082 |
| 17 | MP0003195_calcinosis | 2.08417261 |
| 18 | MP0005332_abnormal_amino_acid | 1.96456767 |
| 19 | MP0010329_abnormal_lipoprotein_level | 1.95341894 |
| 20 | * MP0002970_abnormal_white_adipose | 1.89423793 |
| 21 | MP0009115_abnormal_fat_cell | 1.86932313 |
| 22 | MP0005334_abnormal_fat_pad | 1.86698529 |
| 23 | MP0008775_abnormal_heart_ventricle | 1.75868399 |
| 24 | MP0006035_abnormal_mitochondrial_morpho | 1.74488558 |
| 25 | MP0004043_abnormal_pH_regulation | 1.72643683 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.68652445 |
| 27 | MP0008961_abnormal_basal_metabolism | 1.63923777 |
| 28 | MP0002876_abnormal_thyroid_physiology | 1.62787894 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.58085114 |
| 30 | * MP0002078_abnormal_glucose_homeostasis | 1.56840972 |
| 31 | MP0003011_delayed_dark_adaptation | 1.53035983 |
| 32 | MP0006138_congestive_heart_failure | 1.46130236 |
| 33 | MP0003868_abnormal_feces_composition | 1.46019652 |
| 34 | MP0005448_abnormal_energy_balance | 1.44698599 |
| 35 | MP0000609_abnormal_liver_physiology | 1.40398602 |
| 36 | MP0004087_abnormal_muscle_fiber | 1.34380635 |
| 37 | MP0009379_abnormal_foot_pigmentation | 1.33540629 |
| 38 | MP0010234_abnormal_vibrissa_follicle | 1.29687954 |
| 39 | MP0003724_increased_susceptibility_to | 1.29669117 |
| 40 | MP0005647_abnormal_sex_gland | 1.28214391 |
| 41 | * MP0005452_abnormal_adipose_tissue | 1.26223519 |
| 42 | MP0005085_abnormal_gallbladder_physiolo | 1.25933119 |
| 43 | MP0001544_abnormal_cardiovascular_syste | 1.22207604 |
| 44 | MP0005385_cardiovascular_system_phenoty | 1.22207604 |
| 45 | MP0002972_abnormal_cardiac_muscle | 1.21131771 |
| 46 | MP0004215_abnormal_myocardial_fiber | 1.19791586 |
| 47 | MP0001661_extended_life_span | 1.14820047 |
| 48 | MP0004484_altered_response_of | 1.13666610 |
| 49 | MP0005620_abnormal_muscle_contractility | 1.12995872 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.12038603 |
| 51 | MP0005503_abnormal_tendon_morphology | 1.11548992 |
| 52 | MP0005365_abnormal_bile_salt | 1.09142337 |
| 53 | MP0004233_abnormal_muscle_weight | 1.08904059 |
| 54 | MP0003959_abnormal_lean_body | 1.07753129 |
| 55 | MP0002796_impaired_skin_barrier | 1.04577342 |
| 56 | MP0008438_abnormal_cutaneous_collagen | 1.04206206 |
| 57 | MP0004019_abnormal_vitamin_homeostasis | 1.03211629 |
| 58 | MP0001879_abnormal_lymphatic_vessel | 1.02869905 |
| 59 | MP0010630_abnormal_cardiac_muscle | 1.01003550 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 1.00444468 |
| 61 | MP0004036_abnormal_muscle_relaxation | 0.99904610 |
| 62 | MP0003186_abnormal_redox_activity | 0.98861206 |
| 63 | MP0000627_abnormal_mammary_gland | 0.98688038 |
| 64 | MP0003690_abnormal_glial_cell | 0.97676071 |
| 65 | MP0000759_abnormal_skeletal_muscle | 0.95855047 |
| 66 | MP0004381_abnormal_hair_follicle | 0.94242348 |
| 67 | MP0001727_abnormal_embryo_implantation | 0.94052487 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 0.92712701 |
| 69 | MP0005595_abnormal_vascular_smooth | 0.92548409 |
| 70 | MP0005501_abnormal_skin_physiology | 0.91288995 |
| 71 | MP0002295_abnormal_pulmonary_circulatio | 0.88239514 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 0.86984661 |
| 73 | MP0004084_abnormal_cardiac_muscle | 0.86859764 |
| 74 | MP0002638_abnormal_pupillary_reflex | 0.86528274 |
| 75 | MP0002060_abnormal_skin_morphology | 0.86258307 |
| 76 | MP0000343_altered_response_to | 0.85377598 |
| 77 | MP0004147_increased_porphyrin_level | 0.85274614 |
| 78 | MP0003279_aneurysm | 0.84328519 |
| 79 | MP0003705_abnormal_hypodermis_morpholog | 0.83880636 |
| 80 | MP0003948_abnormal_gas_homeostasis | 0.82651369 |
| 81 | MP0002139_abnormal_hepatobiliary_system | 0.81516062 |
| 82 | MP0010368_abnormal_lymphatic_system | 0.79802703 |
| 83 | MP0002108_abnormal_muscle_morphology | 0.79040272 |
| 84 | MP0000249_abnormal_blood_vessel | 0.78557702 |
| 85 | MP0000749_muscle_degeneration | 0.78456798 |
| 86 | MP0000751_myopathy | 0.77923370 |
| 87 | MP0005266_abnormal_metabolism | 0.76543913 |
| 88 | MP0003953_abnormal_hormone_level | 0.75968407 |
| 89 | MP0002254_reproductive_system_inflammat | 0.75435843 |
| 90 | MP0005275_abnormal_skin_tensile | 0.75298439 |
| 91 | MP0005164_abnormal_response_to | 0.75162065 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.74522273 |
| 93 | MP0009643_abnormal_urine_homeostasis | 0.72671645 |
| 94 | MP0005360_urolithiasis | 0.70908379 |
| 95 | MP0005379_endocrine/exocrine_gland_phen | 0.70037524 |
| 96 | MP0000750_abnormal_muscle_regeneration | 0.69532804 |
| 97 | MP0004272_abnormal_basement_membrane | 0.68508654 |
| 98 | MP0005386_behavior/neurological_phenoty | 0.68397729 |
| 99 | MP0004924_abnormal_behavior | 0.68397729 |
| 100 | MP0000647_abnormal_sebaceous_gland | 0.66121142 |
| 101 | MP0000230_abnormal_systemic_arterial | 0.65698908 |
| 102 | MP0002106_abnormal_muscle_physiology | 0.65386411 |
| 103 | MP0000858_altered_metastatic_potential | 0.64415968 |
| 104 | MP0005388_respiratory_system_phenotype | 0.64304195 |
| 105 | MP0002133_abnormal_respiratory_system | 0.64304195 |
| 106 | MP0005645_abnormal_hypothalamus_physiol | 0.64170032 |
| 107 | MP0008872_abnormal_physiological_respon | 0.62069436 |
| 108 | MP0004858_abnormal_nervous_system | 0.61996074 |
| 109 | MP0000747_muscle_weakness | 0.61959954 |
| 110 | MP0003950_abnormal_plasma_membrane | 0.61268058 |
| 111 | MP0005409_darkened_coat_color | 0.60915855 |
| 112 | MP0002933_joint_inflammation | 0.59485160 |
| 113 | MP0001177_atelectasis | 0.58278248 |
| 114 | MP0002098_abnormal_vibrissa_morphology | 0.58042729 |
| 115 | MP0001216_abnormal_epidermal_layer | 0.57717651 |
| 116 | MP0003566_abnormal_cell_adhesion | 0.57698330 |
| 117 | MP0001958_emphysema | 0.57341051 |
| 118 | MP0002168_other_aberrant_phenotype | 0.57087472 |
| 119 | MP0001764_abnormal_homeostasis | 0.53725841 |
| 120 | MP0001501_abnormal_sleep_pattern | 0.52423098 |
| 121 | MP0002269_muscular_atrophy | 0.51545082 |
| 122 | MP0000767_abnormal_smooth_muscle | 0.51046532 |
| 123 | MP0003137_abnormal_impulse_conducting | 0.50574700 |
| 124 | MP0004085_abnormal_heartbeat | 0.50573723 |
| 125 | MP0003191_abnormal_cellular_cholesterol | 0.49977019 |
| 126 | MP0009672_abnormal_birth_weight | 0.46798034 |
| 127 | MP0003879_abnormal_hair_cell | 0.45802967 |
| 128 | MP0003828_pulmonary_edema | 0.45137258 |
| 129 | MP0005083_abnormal_biliary_tract | 0.44954174 |
| 130 | MP0005376_homeostasis/metabolism_phenot | 0.43915804 |
| 131 | * MP0009642_abnormal_blood_homeostasis | 0.42857979 |
| 132 | MP0005369_muscle_phenotype | 0.41160137 |
| 133 | MP0003136_yellow_coat_color | 0.40548611 |
| 134 | MP0001664_abnormal_digestion | 0.40493431 |
| 135 | MP0002909_abnormal_adrenal_gland | 0.39834519 |
| 136 | MP0001756_abnormal_urination | 0.39432784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 6.49617998 |
| 2 | Hyperglycinuria (HP:0003108) | 5.81146410 |
| 3 | Dicarboxylic aciduria (HP:0003215) | 5.76948978 |
| 4 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 5.76948978 |
| 5 | Myoglobinuria (HP:0002913) | 5.69815407 |
| 6 | Abnormality of fatty-acid metabolism (HP:0004359) | 5.69807231 |
| 7 | Hepatic necrosis (HP:0002605) | 5.52272290 |
| 8 | Rhabdomyolysis (HP:0003201) | 5.20137089 |
| 9 | Generalized aminoaciduria (HP:0002909) | 5.15791094 |
| 10 | Abnormality of glycolysis (HP:0004366) | 4.80192523 |
| 11 | Increased serum pyruvate (HP:0003542) | 4.80192523 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 4.67336629 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.67336629 |
| 14 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.66039006 |
| 15 | Acute necrotizing encephalopathy (HP:0006965) | 4.64086662 |
| 16 | Nausea (HP:0002018) | 4.54945432 |
| 17 | Acute encephalopathy (HP:0006846) | 4.51926237 |
| 18 | Insulin resistance (HP:0000855) | 4.34998660 |
| 19 | Renal cortical cysts (HP:0000803) | 4.30000697 |
| 20 | Increased muscle lipid content (HP:0009058) | 4.25946383 |
| 21 | Myocardial infarction (HP:0001658) | 4.24298118 |
| 22 | Cerebral edema (HP:0002181) | 4.20558914 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 4.20018471 |
| 24 | Increased variability in muscle fiber diameter (HP:0003557) | 4.17745336 |
| 25 | Abnormality of alanine metabolism (HP:0010916) | 4.14906393 |
| 26 | Hyperalaninemia (HP:0003348) | 4.14906393 |
| 27 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.14906393 |
| 28 | Methylmalonic aciduria (HP:0012120) | 4.08189894 |
| 29 | Ketoacidosis (HP:0001993) | 4.04451721 |
| 30 | Conjunctival hamartoma (HP:0100780) | 4.00822032 |
| 31 | Progressive macrocephaly (HP:0004481) | 3.99992184 |
| 32 | Oligomenorrhea (HP:0000876) | 3.89118453 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.86291670 |
| 34 | Protrusio acetabuli (HP:0003179) | 3.82636844 |
| 35 | Hepatocellular necrosis (HP:0001404) | 3.77359054 |
| 36 | Skin nodule (HP:0200036) | 3.66216798 |
| 37 | Hyperammonemia (HP:0001987) | 3.64978120 |
| 38 | Proximal tubulopathy (HP:0000114) | 3.64152430 |
| 39 | Ketosis (HP:0001946) | 3.63890133 |
| 40 | Lactic acidosis (HP:0003128) | 3.62419658 |
| 41 | Hyperglycinemia (HP:0002154) | 3.61437490 |
| 42 | Axonal loss (HP:0003447) | 3.50912704 |
| 43 | Hydroxyprolinuria (HP:0003080) | 3.49736475 |
| 44 | Abnormality of proline metabolism (HP:0010907) | 3.49736475 |
| 45 | Complement deficiency (HP:0004431) | 3.49277319 |
| 46 | Increased CSF lactate (HP:0002490) | 3.49124393 |
| 47 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.41857670 |
| 48 | Lethargy (HP:0001254) | 3.41162923 |
| 49 | Growth hormone excess (HP:0000845) | 3.34642094 |
| 50 | Mitochondrial inheritance (HP:0001427) | 3.34107856 |
| 51 | Pheochromocytoma (HP:0002666) | 3.23702894 |
| 52 | Abnormality of serum amino acid levels (HP:0003112) | 3.21310253 |
| 53 | Subcapsular cataract (HP:0000523) | 3.17033390 |
| 54 | Respiratory failure (HP:0002878) | 3.14422388 |
| 55 | Methylmalonic acidemia (HP:0002912) | 3.10207332 |
| 56 | Long foot (HP:0001833) | 3.07967575 |
| 57 | Bone cyst (HP:0012062) | 3.06753963 |
| 58 | Hemorrhage of the eye (HP:0011885) | 3.06230460 |
| 59 | Abnormality of complement system (HP:0005339) | 2.99927929 |
| 60 | Increased IgE level (HP:0003212) | 2.99535102 |
| 61 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.94441996 |
| 62 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.94441996 |
| 63 | Hypotrichosis (HP:0001006) | 2.90527395 |
| 64 | Vertebral compression fractures (HP:0002953) | 2.90117775 |
| 65 | Hypercholesterolemia (HP:0003124) | 2.89936284 |
| 66 | Neonatal death (HP:0003811) | 2.88683744 |
| 67 | Esophageal neoplasm (HP:0100751) | 2.86080203 |
| 68 | Neoplasm of head and neck (HP:0012288) | 2.86080203 |
| 69 | Pigmentary retinal degeneration (HP:0001146) | 2.84126854 |
| 70 | Abnormal eating behavior (HP:0100738) | 2.81633727 |
| 71 | Neuroendocrine neoplasm (HP:0100634) | 2.81335034 |
| 72 | Palpitations (HP:0001962) | 2.78889615 |
| 73 | Back pain (HP:0003418) | 2.78883754 |
| 74 | Muscle fiber splitting (HP:0003555) | 2.75239737 |
| 75 | Exercise-induced myalgia (HP:0003738) | 2.74909859 |
| 76 | Hypercortisolism (HP:0001578) | 2.74616131 |
| 77 | Vomiting (HP:0002013) | 2.73028429 |
| 78 | Spinal rigidity (HP:0003306) | 2.71268677 |
| 79 | Hypertriglyceridemia (HP:0002155) | 2.69823165 |
| 80 | Nephritis (HP:0000123) | 2.68471066 |
| 81 | Athetosis (HP:0002305) | 2.66455787 |
| 82 | Woolly hair (HP:0002224) | 2.66185907 |
| 83 | Metabolic acidosis (HP:0001942) | 2.65614746 |
| 84 | Increased intramyocellular lipid droplets (HP:0012240) | 2.62164117 |
| 85 | Acanthosis nigricans (HP:0000956) | 2.61398024 |
| 86 | Polyphagia (HP:0002591) | 2.61367797 |
| 87 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.57583632 |
| 88 | Hamartoma of the eye (HP:0010568) | 2.57543620 |
| 89 | Polar cataract (HP:0010696) | 2.55321218 |
| 90 | Exercise intolerance (HP:0003546) | 2.53019094 |
| 91 | Multiple enchondromatosis (HP:0005701) | 2.51214056 |
| 92 | Aortic aneurysm (HP:0004942) | 2.47083811 |
| 93 | Lipid accumulation in hepatocytes (HP:0006561) | 2.44235636 |
| 94 | Pili torti (HP:0003777) | 2.43441423 |
| 95 | Colitis (HP:0002583) | 2.42917313 |
| 96 | Onycholysis (HP:0001806) | 2.41622034 |
| 97 | Lymphangioma (HP:0100764) | 2.39601169 |
| 98 | Prominent supraorbital ridges (HP:0000336) | 2.38159215 |
| 99 | Muscle stiffness (HP:0003552) | 2.37445047 |
| 100 | Abnormality of the periventricular white matter (HP:0002518) | 2.35834695 |
| 101 | Abnormality of the renal cortex (HP:0011035) | 2.33265828 |
| 102 | Amyloidosis (HP:0011034) | 2.32744584 |
| 103 | Difficulty running (HP:0009046) | 2.32086848 |
| 104 | Systemic lupus erythematosus (HP:0002725) | 2.30955985 |
| 105 | Polycythemia (HP:0001901) | 2.30186546 |
| 106 | Lipoatrophy (HP:0100578) | 2.29986443 |
| 107 | Ileus (HP:0002595) | 2.29732884 |
| 108 | Ectopia lentis (HP:0001083) | 2.28431232 |
| 109 | Accelerated skeletal maturation (HP:0005616) | 2.25941630 |
| 110 | Neoplasm of the adrenal gland (HP:0100631) | 2.25777053 |
| 111 | Leukodystrophy (HP:0002415) | 2.25681572 |
| 112 | Optic disc pallor (HP:0000543) | 2.25632983 |
| 113 | Ragged-red muscle fibers (HP:0003200) | 2.21463914 |
| 114 | Epidermoid cyst (HP:0200040) | 2.20621296 |
| 115 | Increased serum lactate (HP:0002151) | 2.18904734 |
| 116 | Abnormal cartilage morphology (HP:0002763) | 2.18791912 |
| 117 | Limb hypertonia (HP:0002509) | 2.17758545 |
| 118 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.13844142 |
| 119 | Neck muscle weakness (HP:0000467) | 2.11161093 |
| 120 | Abnormal hemoglobin (HP:0011902) | 2.10347031 |
| 121 | Striae distensae (HP:0001065) | 2.09032619 |
| 122 | Respiratory distress (HP:0002098) | 2.05313120 |
| 123 | Abnormality of purine metabolism (HP:0004352) | 2.01257872 |
| 124 | Tachypnea (HP:0002789) | 1.99787447 |
| 125 | Hypoalphalipoproteinemia (HP:0003233) | 1.95690442 |
| 126 | Glycosuria (HP:0003076) | 1.95586167 |
| 127 | Abnormality of urine glucose concentration (HP:0011016) | 1.95586167 |
| 128 | Vascular tortuosity (HP:0004948) | 1.95091384 |
| 129 | Delayed gross motor development (HP:0002194) | 1.94679803 |
| 130 | Frequent falls (HP:0002359) | 1.94353916 |
| 131 | Absent eyelashes (HP:0000561) | 1.93911718 |
| 132 | Infantile muscular hypotonia (HP:0008947) | 1.93226287 |
| 133 | Gliosis (HP:0002171) | 1.92878097 |
| 134 | Cerebral aneurysm (HP:0004944) | 1.92589257 |
| 135 | X-linked dominant inheritance (HP:0001423) | 1.90602874 |
| 136 | Facial diplegia (HP:0001349) | 1.90585782 |
| 137 | Large hands (HP:0001176) | 1.89681019 |
| 138 | Shallow orbits (HP:0000586) | 1.86402719 |
| 139 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.85346369 |
| 140 | Neonatal onset (HP:0003623) | 1.84847115 |
| 141 | CNS demyelination (HP:0007305) | 1.83779314 |
| 142 | Prenatal maternal abnormality (HP:0002686) | 1.83020577 |
| 143 | Asymmetric septal hypertrophy (HP:0001670) | 1.82599268 |
| 144 | Gowers sign (HP:0003391) | 1.82343555 |
| 145 | Erythema (HP:0010783) | 1.80993668 |
| 146 | Foot dorsiflexor weakness (HP:0009027) | 1.80911418 |
| 147 | Atrioventricular block (HP:0001678) | 1.78089084 |
| 148 | Cavernous hemangioma (HP:0001048) | 1.76793259 |
| 149 | Cerebral hemorrhage (HP:0001342) | 1.76068032 |
| 150 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.75822655 |
| 151 | Pancreatitis (HP:0001733) | 1.74721307 |
| 152 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.74002376 |
| 153 | Hepatosplenomegaly (HP:0001433) | 1.73855034 |
| 154 | Palmoplantar hyperkeratosis (HP:0000972) | 1.73222463 |
| 155 | Tinnitus (HP:0000360) | 1.73102512 |
| 156 | Neoplasm of the rectum (HP:0100743) | 1.72980750 |
| 157 | Easy fatigability (HP:0003388) | 1.72709234 |
| 158 | Xanthomatosis (HP:0000991) | 1.71431539 |
| 159 | Hyperglycemia (HP:0003074) | 1.71394391 |
| 160 | Premature rupture of membranes (HP:0001788) | 1.70755553 |
| 161 | Decreased circulating renin level (HP:0003351) | 1.70590088 |
| 162 | Increased connective tissue (HP:0009025) | 1.70401879 |
| 163 | Brushfield spots (HP:0001088) | 1.69520495 |
| 164 | Ankle contracture (HP:0006466) | 1.67980817 |
| 165 | Broad metatarsal (HP:0001783) | 1.67363179 |
| 166 | Increased mean platelet volume (HP:0011877) | 1.67072708 |
| 167 | Toxemia of pregnancy (HP:0100603) | 1.65743450 |
| 168 | Potter facies (HP:0002009) | 1.65580593 |
| 169 | Facial shape deformation (HP:0011334) | 1.65580593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK4 | 6.07916856 |
| 2 | PDK3 | 6.07916856 |
| 3 | BCKDK | 6.07104957 |
| 4 | CAMK1D | 4.67904737 |
| 5 | TRIB3 | 4.44769514 |
| 6 | PDK2 | 4.04443611 |
| 7 | CAMK1G | 3.25794338 |
| 8 | NME2 | 3.13338335 |
| 9 | SIK1 | 2.95713954 |
| 10 | TESK1 | 2.58198382 |
| 11 | PKN2 | 2.27638976 |
| 12 | STK38L | 2.23121969 |
| 13 | PRKAA2 | 2.05571415 |
| 14 | LATS1 | 1.80834674 |
| 15 | CDK9 | 1.40845894 |
| 16 | EPHB1 | 1.37717575 |
| 17 | RIPK4 | 1.35027224 |
| 18 | TGFBR2 | 1.30213809 |
| 19 | LATS2 | 1.23139922 |
| 20 | ERN1 | 1.22077668 |
| 21 | PINK1 | 1.21697772 |
| 22 | STK24 | 1.19127859 |
| 23 | MOS | 1.13178774 |
| 24 | PRPF4B | 1.07564118 |
| 25 | TRPM7 | 1.07360223 |
| 26 | PDPK1 | 1.03994185 |
| 27 | CAMKK2 | 1.00636313 |
| 28 | IRAK3 | 0.99878200 |
| 29 | TIE1 | 0.99837146 |
| 30 | CSK | 0.98800472 |
| 31 | PIK3CA | 0.97448851 |
| 32 | NLK | 0.95682261 |
| 33 | PRKAA1 | 0.92483787 |
| 34 | STK3 | 0.91863812 |
| 35 | JAK3 | 0.86641181 |
| 36 | PRKD3 | 0.86553594 |
| 37 | EPHB2 | 0.86009894 |
| 38 | PDK1 | 0.85305485 |
| 39 | PTK2 | 0.83972313 |
| 40 | CDC42BPA | 0.83912159 |
| 41 | MAP2K1 | 0.79027328 |
| 42 | ZAP70 | 0.78435808 |
| 43 | FES | 0.77669995 |
| 44 | MAPKAPK3 | 0.73097984 |
| 45 | RIPK1 | 0.72844343 |
| 46 | TTN | 0.72581440 |
| 47 | ADRBK1 | 0.71245448 |
| 48 | TYK2 | 0.71076004 |
| 49 | LMTK2 | 0.70685788 |
| 50 | CDK4 | 0.66915967 |
| 51 | DAPK3 | 0.63291255 |
| 52 | PDGFRA | 0.63236038 |
| 53 | EEF2K | 0.62796108 |
| 54 | MAPK7 | 0.60986612 |
| 55 | NEK9 | 0.60954637 |
| 56 | IRAK1 | 0.60043779 |
| 57 | KSR2 | 0.58689541 |
| 58 | STK38 | 0.58340001 |
| 59 | ICK | 0.57601244 |
| 60 | CAMK1 | 0.57368115 |
| 61 | JAK1 | 0.57183100 |
| 62 | PAK2 | 0.56177111 |
| 63 | INSRR | 0.55512898 |
| 64 | MAPK3 | 0.55107424 |
| 65 | PDGFRB | 0.54869632 |
| 66 | MARK2 | 0.54464451 |
| 67 | PTK6 | 0.54271442 |
| 68 | KIT | 0.54141027 |
| 69 | MAP2K4 | 0.53536080 |
| 70 | PRKG1 | 0.53491126 |
| 71 | PRKACG | 0.53340457 |
| 72 | TYRO3 | 0.52186718 |
| 73 | EIF2AK2 | 0.51842834 |
| 74 | CAMKK1 | 0.51486878 |
| 75 | ABL2 | 0.50116083 |
| 76 | MAPKAPK5 | 0.49144888 |
| 77 | PRKCH | 0.48148052 |
| 78 | PHKG1 | 0.47902729 |
| 79 | PHKG2 | 0.47902729 |
| 80 | PLK4 | 0.47613132 |
| 81 | PRKD1 | 0.47196672 |
| 82 | MAPK12 | 0.46619048 |
| 83 | KDR | 0.45820651 |
| 84 | MAP3K1 | 0.44667913 |
| 85 | ILK | 0.43948191 |
| 86 | GSK3A | 0.43580298 |
| 87 | MAP3K9 | 0.43563758 |
| 88 | MYLK | 0.42562802 |
| 89 | SGK3 | 0.42458472 |
| 90 | FER | 0.42452175 |
| 91 | PKN1 | 0.42123607 |
| 92 | PRKACB | 0.41531407 |
| 93 | IGF1R | 0.41433363 |
| 94 | SGK2 | 0.40973161 |
| 95 | TGFBR1 | 0.40294085 |
| 96 | MST1R | 0.40257224 |
| 97 | MAPK11 | 0.39147715 |
| 98 | RPS6KA3 | 0.38919770 |
| 99 | MAP3K13 | 0.38727825 |
| 100 | JAK2 | 0.38087718 |
| 101 | PRKD2 | 0.37785404 |
| 102 | MAP3K7 | 0.35553352 |
| 103 | ABL1 | 0.35302192 |
| 104 | FGFR3 | 0.34991409 |
| 105 | CDK6 | 0.34587976 |
| 106 | AKT2 | 0.34511916 |
| 107 | RET | 0.33962032 |
| 108 | YES1 | 0.33021063 |
| 109 | MTOR | 0.30643269 |
| 110 | FLT3 | 0.30516839 |
| 111 | FRK | 0.30026076 |
| 112 | DAPK2 | 0.29956104 |
| 113 | INSR | 0.29458752 |
| 114 | TBK1 | 0.28021852 |
| 115 | FGFR4 | 0.26435862 |
| 116 | NTRK3 | 0.26337326 |
| 117 | LRRK2 | 0.25526774 |
| 118 | STK11 | 0.22896111 |
| 119 | PLK2 | 0.22216963 |
| 120 | STK39 | 0.20586968 |
| 121 | WNK4 | 0.20363243 |
| 122 | BMX | 0.20270939 |
| 123 | EPHA3 | 0.19381059 |
| 124 | RPS6KB1 | 0.18125463 |
| 125 | PRKCE | 0.18057820 |
| 126 | PRKACA | 0.17635368 |
| 127 | ARAF | 0.17095425 |
| 128 | MAPK4 | 0.16978832 |
| 129 | MAP3K6 | 0.15696892 |
| 130 | CDK5 | 0.15602637 |
| 131 | PRKCZ | 0.15168936 |
| 132 | GRK5 | 0.14404685 |
| 133 | TTK | 0.14091860 |
| 134 | CAMK2G | 0.13378704 |
| 135 | NEK1 | 0.12563861 |
| 136 | SGK223 | 0.12535713 |
| 137 | SGK494 | 0.12535713 |
| 138 | BCR | 0.12527022 |
| 139 | PTK2B | 0.12493767 |
| 140 | DDR2 | 0.12389059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.35628669 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 5.26962182 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.57111898 |
| 4 | Fatty acid metabolism_Homo sapiens_hsa01212 | 4.00864227 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.69659024 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.57959049 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.25491559 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.17324075 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.14385902 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.90633051 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.74792042 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.48056439 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.37443634 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.30470189 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 2.25963970 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.25304016 |
| 17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.05474793 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90939226 |
| 19 | Alzheimers disease_Homo sapiens_hsa05010 | 1.70995523 |
| 20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.69013048 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.64502327 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.63811164 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40836567 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.33779976 |
| 25 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.31046701 |
| 26 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19351827 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18364401 |
| 28 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.12284572 |
| 29 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.06210475 |
| 30 | Galactose metabolism_Homo sapiens_hsa00052 | 0.98912117 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.95018869 |
| 32 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.90685182 |
| 33 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.88518651 |
| 34 | Insulin resistance_Homo sapiens_hsa04931 | 0.81343287 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79908507 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78852182 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.77504681 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.74238811 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69456922 |
| 40 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69204996 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.63631486 |
| 42 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60777074 |
| 43 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58653414 |
| 44 | Malaria_Homo sapiens_hsa05144 | 0.57528685 |
| 45 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51236397 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50394057 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44924927 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.44647983 |
| 49 | Focal adhesion_Homo sapiens_hsa04510 | 0.44384715 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.42149271 |
| 51 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41890547 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 0.41362446 |
| 53 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39304400 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38321796 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31816759 |
| 56 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31590813 |
| 57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.27398675 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.26566866 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.25431337 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.24953813 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.24195162 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.21899143 |
| 63 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.21428745 |
| 64 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.19784434 |
| 65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.19101967 |
| 66 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.16902614 |
| 67 | Renin secretion_Homo sapiens_hsa04924 | 0.16823890 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.16820579 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.16746084 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.15499809 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14743767 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.14630155 |
| 73 | Morphine addiction_Homo sapiens_hsa05032 | 0.14041143 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.14040862 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.13207528 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.12720280 |
| 77 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.11776729 |
| 78 | Pertussis_Homo sapiens_hsa05133 | 0.10134313 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.08479983 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.07365179 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.07302392 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.06725529 |
| 83 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.06634390 |
| 84 | Salivary secretion_Homo sapiens_hsa04970 | 0.06575253 |
| 85 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.05943259 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.05833133 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.05808881 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.05600916 |
| 89 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.05600835 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.05374574 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.05328622 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.05203244 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.04676293 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.04472999 |
| 95 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.04283121 |
| 96 | Long-term potentiation_Homo sapiens_hsa04720 | 0.04027697 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.03600302 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.03499562 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.03141022 |
| 100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03104386 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.02922345 |
| 102 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.01574463 |
| 103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.01036206 |
| 104 | Viral myocarditis_Homo sapiens_hsa05416 | 0.00869805 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.00671903 |
| 106 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.00116759 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.1248481 |
| 108 | Protein export_Homo sapiens_hsa03060 | -0.1220722 |
| 109 | Calcium signaling pathway_Homo sapiens_hsa04020 | -0.1186749 |
| 110 | Legionellosis_Homo sapiens_hsa05134 | -0.1074706 |
| 111 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0981213 |
| 112 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0919191 |
| 113 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0805492 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0790355 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0753804 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0746460 |
| 117 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.0704890 |
| 118 | Tyrosine metabolism_Homo sapiens_hsa00350 | -0.0618875 |
| 119 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.0547839 |
| 120 | cAMP signaling pathway_Homo sapiens_hsa04024 | -0.0526501 |
| 121 | Phenylalanine metabolism_Homo sapiens_hsa00360 | -0.0520805 |
| 122 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | -0.0503934 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | -0.0490959 |
| 124 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | -0.0465634 |
| 125 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0453723 |
| 126 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0383263 |
| 127 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | -0.0347753 |
| 128 | ABC transporters_Homo sapiens_hsa02010 | -0.0343990 |
| 129 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | -0.0250573 |
| 130 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0140228 |
| 131 | Retinol metabolism_Homo sapiens_hsa00830 | -0.0011485 |

